Gunter Haesaerts, founder and CEO of Pharmatoka (center) accepted the 2017 Varro E. Tyler Commercial Investment in Phytomedicinal Research Award from ABC’s Mark Blumenthal and Stefan Gafner.
Pharmatoka SAS specializes in the research, development, and production of herbal dietary supplements for urogenital health conditions. More specifically, Pharmatoka has focused on researching its standardized cranberry (Vaccinium macrocarpon) extract and its effects on urinary tract health.
“Pharmatoka is an excellent example of a phytomedicine manufacturer that has focused on funding clinical research on its key formulation, and, as such, is highly deserving of the ABC Tyler Award,” said Blumenthal. “Pharmatoka is respected for its research leadership on cranberry, and its research has helped set a therapeutic standard for cranberry extracts.”
“Pioneering the fundamental science of cranberry PACs and clinical observation of bacterial anti-adhesion was challenging but rewarding in the end,” said Haesaerts. “All that work eventually led to the creation of the first-ever cranberry PAC-based traditional herbal medicine,” he added, referring to the European regulatory approval of a cranberry herbal medicine based on traditional use and modern research.